In this post hoc analysis, the estimated cost change associated with each unit difference in body-mass index (BMI) and potential savings that could be achieved via weight loss with phentermine and topiramate extended-release (PHEN/TPM ER) were evaluated.Latts...
Phentermine/Topiramate Combination of phentermine and the anticonvulsant topiramate (Qsymia). This drug induces more weight loss than phentermine alone. It is contraindicated in pregnancy, thyroid disease, and glaucoma. Lorcaserin Lorcaserin (Belviq) is a 5-HT2c serotonin receptor antagonist that has anor...
Methods for treating obesity, conditions associated with obesity, and other indications are also provided, as are compositions and dosage forms containing low doses of phentermine and topiramate, e.g., 3.75 mg phentermine and 23 mg topiramate.Inventors: Najaraian, Thomas (Los Osos, CA, US) Ta...
In comparison with different weight loss combinations, the Phentermine and Topiramate combination is associated with the highest odds of weight loss which is 5% of initial body weight.Researches have shown phentermine and topiramate combinationis the best one yet as a weight los...
Qsymia is a prescription medicine that contains phentermine and topiramate extended-release. Qsymia may help adults and children 12 years and older with obesity, or some adults with overweight who also have weight-related medical problems, to help them lose excess body weight and keep the weight ...
PCV37 - Comorbidity Cost Savings Over 2 Years Of Treatment With Phentermine And Topiramate Extended-Release (Phen/Tpm Er) In An Overweight And Obese Populationdoi:10.1016/j.jval.2014.03.631R. CarltonE. ZagadailovT. BramleyW. LiuS. Karnawat...